> top > docs > PMC:7205724 > spans > 22937-23259 > annotations

PMC:7205724 / 22937-23259 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
808 251-254 Gene denotes IL6 Gene:3569
809 63-71 Species denotes patients Tax:9606
810 160-168 Species denotes patients Tax:9606
811 38-49 Chemical denotes tocilizumab MESH:C502936
812 129-140 Chemical denotes Tocilizumab MESH:C502936
813 97-105 Disease denotes COVID-19 MESH:C000657245
814 174-182 Disease denotes COVID-19 MESH:C000657245
815 209-227 Disease denotes hyper inflammation MESH:D007249

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T166 266-274 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T178 97-105 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T179 174-182 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T180 215-227 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T174 38-49 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T23 266-281 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes platelet counts http://purl.bioontology.org/ontology/MEDDRA/10035525

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T219 97-105 Species denotes COVID-19 NCBItxid:2697049
T220 174-182 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T187 0-106 Sentence denotes There are ongoing clinical trials for tocilizumab treatment in patients with moderate and severe COVID-19.
T188 107-322 Sentence denotes Currently, the use of Tocilizumab is recommended for patients with COVID-19 who have warning signs of hyper inflammation, as can be measured by IL6, ferritin, platelet counts, inflammatory markers, and H score [28].

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
811 38-49 Chemical denotes tocilizumab MESH:C502936
809 63-71 Species denotes patients Tax:9606
813 97-105 Disease denotes COVID-19 MESH:C000657245
812 129-140 Chemical denotes Tocilizumab MESH:C502936
810 160-168 Species denotes patients Tax:9606
814 174-182 Disease denotes COVID-19 MESH:C000657245
815 209-227 Disease denotes hyper inflammation MESH:D007249
808 251-254 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T2216 251-254 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T2260 256-264 Protein denotes ferritin https://www.uniprot.org/uniprot/Q26061

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T24269 0-5 EX denotes There
T26765 6-9 VBP denotes are
T84711 10-17 VBG denotes ongoing
T74304 18-26 JJ denotes clinical
T68003 27-33 NNS denotes trials
T5000 34-37 IN denotes for
T64198 38-49 NN denotes tocilizumab
T83078 50-59 NN denotes treatment
T11331 60-62 IN denotes in
T42834 63-71 NNS denotes patients
T27205 72-76 IN denotes with
T23786 77-85 JJ denotes moderate
T45333 86-89 CC denotes and
T9137 90-96 JJ denotes severe
T27842 97-105 NN denotes COVID-19
T92236 107-116 RB denotes Currently
T32112 116-117 -COMMA- denotes ,
T54987 118-121 DT denotes the
T85855 122-125 NN denotes use
T69355 126-128 IN denotes of
T40115 129-140 NNP denotes Tocilizumab
T10850 141-143 VBZ denotes is
T78367 144-155 VBN denotes recommended
T33042 156-159 IN denotes for
T36466 160-168 NNS denotes patients
T61983 169-173 IN denotes with
T2749 174-182 NN denotes COVID-19
T17580 183-186 WP denotes who
T69055 187-191 VBP denotes have
T71996 192-199 VBG denotes warning
T59356 200-205 NNS denotes signs
T65527 206-208 IN denotes of
T99769 209-214 NN denotes hyper
T44301 215-227 NN denotes inflammation
T54453 227-228 -COMMA- denotes ,
T58078 229-231 IN denotes as
T75237 232-235 MD denotes can
T7496 236-238 VB denotes be
T53845 239-247 VBN denotes measured
T78207 248-250 IN denotes by
T88455 251-254 NN denotes IL6
T77671 254-255 -COMMA- denotes ,
T67481 256-264 NN denotes ferritin
T99390 264-265 -COMMA- denotes ,
T23484 266-274 NN denotes platelet
T65701 275-281 NNS denotes counts
T30323 281-282 -COMMA- denotes ,
T72053 283-295 JJ denotes inflammatory
T81575 296-303 NNS denotes markers
T96428 303-304 -COMMA- denotes ,
T36542 305-308 CC denotes and
T88469 309-310 NN denotes H
T51141 311-316 NN denotes score
T97739 317-318 -LRB- denotes [
T29313 318-320 CD denotes 28
T54016 320-321 -RRB- denotes ]
R66954 T24269 T26765 arg1Of There,are
R94262 T68003 T26765 arg2Of trials,are
R16905 T68003 T84711 arg1Of trials,ongoing
R34037 T68003 T74304 arg1Of trials,clinical
R29518 T68003 T5000 arg1Of trials,for
R26554 T83078 T5000 arg2Of treatment,for
R27449 T83078 T64198 arg1Of treatment,tocilizumab
R95470 T83078 T11331 arg1Of treatment,in
R78533 T42834 T11331 arg2Of patients,in
R30062 T42834 T27205 arg1Of patients,with
R17601 T27842 T27205 arg2Of COVID-19,with
R89241 T27842 T23786 arg1Of COVID-19,moderate
R28465 T23786 T45333 arg1Of moderate,and
R59576 T9137 T45333 arg2Of severe,and
R97104 T27842 T9137 arg1Of COVID-19,severe
R53041 T58078 T92236 arg1Of as,Currently
R61441 T58078 T32112 arg1Of as,","
R66943 T85855 T54987 arg1Of use,the
R89881 T85855 T69355 arg1Of use,of
R92489 T40115 T69355 arg2Of Tocilizumab,of
R4907 T85855 T10850 arg1Of use,is
R54223 T78367 T10850 arg2Of recommended,is
R26904 T85855 T78367 arg2Of use,recommended
R93944 T78367 T33042 arg1Of recommended,for
R96954 T36466 T33042 arg2Of patients,for
R92720 T36466 T61983 arg1Of patients,with
R61251 T2749 T61983 arg2Of COVID-19,with
R60119 T36466 T17580 arg1Of patients,who
R35135 T36466 T69055 arg1Of patients,have
R48731 T59356 T69055 arg2Of signs,have
R72772 T59356 T71996 arg1Of signs,warning
R6154 T59356 T65527 arg1Of signs,of
R22400 T44301 T65527 arg2Of inflammation,of
R13264 T44301 T99769 arg1Of inflammation,hyper
R72983 T78367 T54453 arg1Of recommended,","
R85482 T78367 T58078 arg1Of recommended,as
R94310 T53845 T58078 arg2Of measured,as
R71674 T85855 T75237 arg1Of use,can
R96842 T53845 T75237 arg2Of measured,can
R13154 T85855 T7496 arg1Of use,be
R84932 T53845 T7496 arg2Of measured,be
R87538 T85855 T53845 arg2Of use,measured
R19206 T53845 T78207 arg1Of measured,by
R40933 T36542 T78207 arg2Of and,by
R89076 T88455 T77671 arg1Of IL6,","
R2282 T67481 T77671 arg2Of ferritin,","
R15531 T77671 T99390 arg1Of ",",","
R60586 T65701 T99390 arg2Of counts,","
R8993 T65701 T23484 arg1Of counts,platelet
R92565 T99390 T30323 arg1Of ",",","
R21977 T81575 T30323 arg2Of markers,","
R92122 T81575 T72053 arg1Of markers,inflammatory
R15083 T36542 T96428 arg1Of and,","
R68271 T30323 T36542 arg1Of ",",and
R27501 T51141 T36542 arg2Of score,and
R83390 T51141 T88469 arg1Of score,H
R41615 T51141 T97739 arg1Of score,[
R59110 T29313 T97739 arg2Of 28,[
R77316 T54016 T97739 arg3Of ],[

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T32 215-227 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T166 266-274 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T168 97-105 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T169 174-182 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T170 215-227 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T28 215-227 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T28 215-227 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T187 0-106 Sentence denotes There are ongoing clinical trials for tocilizumab treatment in patients with moderate and severe COVID-19.
T188 107-322 Sentence denotes Currently, the use of Tocilizumab is recommended for patients with COVID-19 who have warning signs of hyper inflammation, as can be measured by IL6, ferritin, platelet counts, inflammatory markers, and H score [28].